How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Proton Therapy System Market
- By Component: Cyclotron, Synchrotron, Gantry, Beam Delivery System, Patient Positioning System, Imaging System
- By Application: Head and Neck Cancer, Prostate Cancer, Lung Cancer, Pediatric Cancer, Brain Tumors, Other Solid Tumors
- By End User: Hospitals, Cancer Research Centers, Specialty Oncology Clinics
- By Technology: Passive Scattering Proton Therapy, Pencil Beam Scanning (PBS)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cyclotron leads By Component at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 268 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 12 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Proton Therapy System Market report
A complete, evidence-based study - 11 chapters and 112 sections covering market size, segmentation across 4 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Component 6
Application 6
End User 3
Technology 2
Companies profiled
IBA (Ion Beam Applications)
Varian Medical Systems (a Siemens Healthineers company)
Hitachi Ltd.
Mevion Medical Systems
Sumitomo Heavy Industries Ltd.
ProTom International
Advanced Oncotherapy
Mitsubishi Electric Corporation
Sumitomo Electric Industries Ltd.
P-Cure Ltd.
Ion Beam Applications (IBA)
ProNova Solutions
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →IBA (Ion Beam Applications)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Hitachi Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mevion Medical Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sumitomo Heavy Industries Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ProTom International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Advanced Oncotherapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Mitsubishi Electric Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sumitomo Electric Industries Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →P-Cure Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Ion Beam Applications (IBA)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →ProNova Solutions
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,789M by 2033 · 10.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cyclotron49.5
- Synchrotron7.0
- Gantry12.1
- Beam Delivery System6.8
- Patient Positioning System11.1
- Imaging System13.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$861.2M → $1,889M · 10.3%
Europe$600.3M → $1,328M · 10.4%
Asia Pacific$548.1M → $1,247M · 10.8%
Latin America$339.3M → $844.2M · 12.1%
Middle East and Africa$261.0M → $550.6M · 9.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.422026
10.442027
10.442028
10.472029
10.472030
10.492031
10.492032
10.512033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- IBA (Ion Beam Applications)18.8
- Varian Medical Systems (a Siemens Healthineers company)12.2
- Hitachi Ltd.9.3
- Mevion Medical Systems13.5
- Sumitomo Heavy Industries Ltd.7.4
- ProTom International10.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Component24.7%
Application33.0%
End User21.7%
Technology20.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe22.7
- Asia Pacific21.3
- Latin America14.4
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| IBA (Ion Beam Applications) | 86 | 75 | 95 | 73 | 83 | 75 | 81 |
| Varian Medical Systems (a Siemens Healthineers company) | 76 | 92 | 85 | 85 | 80 | 86 | 84 |
| Hitachi Ltd. | 86 | 70 | 86 | 81 | 69 | 81 | 79 |
| Mevion Medical Systems | 59 | 63 | 62 | 78 | 76 | 79 | 70 |
| Sumitomo Heavy Industries Ltd. | 76 | 67 | 57 | 71 | 55 | 67 | 66 |
| ProTom International | 52 | 48 | 65 | 47 | 52 | 68 | 55 |
| Advanced Oncotherapy | 47 | 63 | 41 | 50 | 63 | 63 | 55 |
| Mitsubishi Electric Corporation | 49 | 57 | 52 | 43 | 49 | 56 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- IBA (Ion Beam Applications)
- Varian Medical Systems (a Siemens Healthineers company)
- Hitachi Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| IBA (Ion Beam Applications) | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Varian Medical Systems (a Siemens Healthineers company) | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Hitachi Ltd. | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Mevion Medical Systems | ◐ | − | ✓ | ✓ | ◐ | ✓ |
| Sumitomo Heavy Industries Ltd. | ✓ | − | − | ✓ | − | ✓ |
| ProTom International | ◐ | − | ✓ | ◐ | ◐ | ◐ |
| Advanced Oncotherapy | ◐ | − | ◐ | − | − | ◐ |
| Mitsubishi Electric Corporation | − | ◐ | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Varian Medical Systems (a Siemens Healthineers company)84
2IBA (Ion Beam Applications)81
3Hitachi Ltd.79
4Mevion Medical Systems70
5Sumitomo Heavy Industries Ltd.66
6ProTom International55
7Advanced Oncotherapy55
8Mitsubishi Electric Corporation51
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
IBA (Ion Beam Applications)Varian Medical Systems (a Siemens Healthineers company)Hitachi Ltd.
Challenger1
Strong scale, closing on the leaders.
Mevion Medical Systems
Contender1
Focused players with pockets of strength.
Sumitomo Heavy Industries Ltd.
Niche3
Specialists in a single segment or region.
ProTom InternationalAdvanced OncotherapyMitsubishi Electric Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Component in North America, then scale across Proton Therapy System Market — a $321M beachhead inside a $5.67B market.
Beachhead (SOM)$321Mobtainable near-term
Serviceable (SAM)$2.01Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Cyclotron
Best fit — highest urgency & budget in Component.
Economic buyer76 fit
Synchrotron
Strong fit — clear ROI and a fast path to value.
End user69 fit
Gantry
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Component in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Component leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Proton Therapy System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation12%
Closed-won7%
$13.3KCAC
$63KLTV
4.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Proton Therapy System Market is a high-growth opportunity — $10.8B by 2033, compounding at 10.8%.
TAM · 2025$4.76Btoday
TAM · 2033$10.8Bforecast
CAGR10.8%2027–2033
Cumulative$66.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.8BTotal addressable market
SAM$4.01BServiceable available market
SOM$750MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.8% CAGR
Demand compounds through 2033, outpacing GDP across Component.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Component moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.8BLarge & growingTAM by 2033 at 10.8% CAGR
$4.01BServiceable nowreachable with today’s model
$750MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.43BBear7.0% CAGR
$10.8BBase10.8% CAGR
$13.8BBull14.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Proton Therapy System Market — a $7.17B market by 2033. Plan: grow share from 8.1% to 17.3%.
Market size · 2033$7.17Btotal addressable
Market CAGR9.4%2027–2033
Target share17.3%from 8.1% today
Revenue ambition$1.24Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 17.3% | Ahead |
| Revenue | $541M | $1.24B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 33.0% | 40.5% | On track |
| Customer retention | 85.9% | 92.9% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Component
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Component share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $139M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Component leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Proton Therapy System Market conversation — a $3.55B market you can size, segment and defend in minutes.
Market size · 2033$3.55Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,597+accounts in scope
Typical ROI6.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Component
Goal Grow share in Component
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.9×return on cost, year one
< 3 mopayback period
$92K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
IBA (Ion Beam Applications)Varian Medical Systems (a Siemens Healthineers company)Hitachi Ltd.Mevion Medical SystemsSumitomo Heavy Industries Ltd.ProTom InternationalAdvanced OncotherapyMitsubishi Electric Corporation+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Proton Therapy System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Proton Therapy System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Protonic Ceramic Fuel Cell Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportProtopine Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportProtractors & Squares Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportProustite Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportProvider Data Management (PDM) Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportProving Ring Penetrometer Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportProvisional Materials - Indirect Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportProvitamins and Vitamins Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportProxan Sodium Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportProximal Femoral Locking Plate Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportProximity Market
Market size, share, segmentation and regional forecast.
$529M market · 2025 base year
View reportProximity Payment Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.